GlassScriptPhysician profile
Eran M Hahn
NPI 1952396251
$3,935.39
in general payments reported to CMS, 2019-2025
33 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $173 · 2021: $1,040 · 2022: $750 · 2023: $595 · 2024: $574 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $788.49 | 2019-2025 | |
| Evofem Biosciences, INC. | $355.52 | 2021-2025 | Phexxi, Solosec, Phexx |
| Amgen INC. | $238.83 | 2019-2024 | Evenity, Prolia |
| Mission Pharmacal Company | $219.74 | 2019-2021 | |
| Pfizer INC. | $213.91 | 2019-2024 | |
| Astellas Pharma US INC | $193.44 | 2023-2025 | Veozah |
| Myovant Sciences INC. | $184.29 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $167.82 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $166.83 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $163.38 | 2021-2025 | Slynd |
| Hologic Sales and Service, LLC | $160.42 | 2019-2023 | Third Wave, Aptima, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $121.47 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $120.37 | 2021-2023 | |
| Intuitive Surgical, INC. | $100.96 | 2022 | |
| Organon LLC | $87.90 | 2023-2025 | Nexplanon |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $85.90 | 2021-2023 | Balcoltra |
| Agile Therapeutics, INC. | $84.80 | 2021-2024 | Twirla |
| Lupin INC. | $61.39 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $58.25 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.56 | 2021-2024 | Xifaxan |
| Ethicon US, LLC | $45.53 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $42.85 | 2019 | |
| Becton, Dickinson and Company | $38.79 | 2024 | Bd Onclarity |
| Daiichi Sankyo INC. | $32.61 | 2019-2022 | |
| Allergan, INC. | $26.16 | 2019 | |
| Millicent US INC | $19.48 | 2024 | Intrarosa |
| Provepharm INC. | $18.33 | 2025 | Bludigo |
| Covidien LP | $17.58 | 2019 | |
| Trevena, INC. | $15.09 | 2021 | |
| Scynexis, INC. | $13.83 | 2021 | |
| Duchesnay USA Incorporated | $13.44 | 2019 | |
| Optumhealth Care Solutions, LLC | $13.30 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Phathom Pharmaceuticals, INC. | $13.13 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eran Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.